about
Exploiting Epigenetic Alterations in Prostate Cancer.A mathematical theory of the transcription repression (TR) therapy of cancer - whether and how it may work.Twenty years of menin: emerging opportunities for restoration of transcription in MEN1.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.Is TFIIH the new Achilles heel of cancer cells?Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.Molecular determinants of prostate cancer metastasis.The emerging roles of CDK12 in tumorigenesis.ER stress signaling promotes the survival of cancer 'persister cells' tolerant to EGFR tyrosine kinase inhibitors.Current Progress in EBV-Associated B-Cell Lymphomas.Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.Metabolism and Transcription in Cancer: Merging Two Classic Tales.Targeting cistrome and dysregulated transcriptome of post-MPN sAML.Widespread transcriptional pausing and elongation control at enhancers.RIP140 and LCoR expression in gastrointestinal cancers.A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.RaMP: A Comprehensive Relational Database of Metabolomics Pathways for Pathway Enrichment Analysis of Genes and Metabolites.Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.BART: a transcription factor prediction tool with query gene sets or epigenomic profiles.A switch in transcription and cell fate governs the onset of an epigenetically-deregulated tumor in Drosophila.Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.A Caenorhabditis elegans protein with a PRDM9-like SET domain localizes to chromatin-associated foci and promotes spermatocyte gene expression, sperm production and fertility.Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics.Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.The contributions of cancer cell metabolism to metastasisZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasisA distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutationsAn Introduction to the Mathematical Modeling in the Study of Cancer Systems BiologyDisabling an oncogenic transcription factor by targeting of control kinasesEndogenous HIF2A reporter systems for high-throughput functional screeningNext-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase SeparationTBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
P2860
Q33755160-83B2F671-5EF0-4440-9F64-BF52329F36C6Q33888911-0FACBD25-BBF5-4EDC-96F6-1C2B7B1B7A58Q38642042-0BC5028B-DF24-4463-AA33-6EE6932644FEQ39441366-9A43C5EE-74B4-4CB0-8D5B-3F741C81FDE5Q42513451-6D31C328-90AD-4975-AFD0-287D8680D97FQ46420204-7F07A9DD-2C59-4F1B-8CFF-7A3EEA363462Q46436702-18A30488-7102-41AD-A8A1-ADE6E1277E8EQ47103669-432ED689-E6C1-4F9F-8AF4-5F91C552FF91Q47155353-B4232708-FCE7-49BC-B287-D455011A2D56Q47273602-BCBDE38C-784C-4A64-B00E-F1EA1C26E688Q47606345-1A6FD9C7-B592-4E49-A101-05E4526134B4Q48171311-5A1F7228-DDE3-41C3-BACC-C6CADEF9BCC6Q49306241-027553EE-F2D8-43F7-9F30-CD07D2D9FD4BQ49344267-B8FDFCF5-6305-4667-8D67-482A934A272CQ49598111-84878359-8F8F-4D32-A405-E1A7D4E4E76EQ49727328-7B1B8F01-D2C6-46D0-A5CC-A38221189135Q50001782-A4FCD5FB-3002-4290-A401-CB65C65911BBQ50547887-9DC9A807-9B51-4475-ACF2-8E3C29A3E2EDQ52374814-7B358C41-C823-49E2-A18D-B850D0622475Q52602401-E8B0B53D-6459-4105-B77A-093AC3FAE5D9Q52613229-6E22FF98-D07C-4D92-9ADD-C1460AAF45BAQ52645535-A0B1D692-357D-41FC-9E6D-C7669B661643Q52673134-A0E3E114-31DD-4096-9857-314855E3330CQ55177522-68ECA77F-E284-416B-8F50-730AB759C331Q55253157-533BA1A9-26B9-4479-982F-4FCF35252E76Q55260615-418DFF7A-6982-4F7D-ADC4-A0742D8AF3A1Q55492673-E1F5C17C-D6D7-417D-BA56-EBE82E74CB88Q57188839-B23E4DC1-1798-4ACA-A226-3E049FFFA2B3Q57822867-C308C51B-59DB-44A8-84E2-3F02E3B09D59Q58718413-24397AC6-D9AB-4E8F-B09D-0BE0D2FAC38EQ58747248-13D71E23-2343-450D-BB78-451A7D210C4AQ58767930-043DF3B5-89EA-44F1-9845-7D56D30848A7Q58786758-19539642-3CAF-4F7F-A5E3-7FE3D5BE220EQ58798742-5AC3EE61-6C10-489A-ADCD-621BCA24BC00Q59134749-658BD4F1-7531-431E-9CC8-145FC6692095
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Transcriptional Addiction in Cancer.
@en
Transcriptional Addiction in Cancer.
@nl
type
label
Transcriptional Addiction in Cancer.
@en
Transcriptional Addiction in Cancer.
@nl
prefLabel
Transcriptional Addiction in Cancer.
@en
Transcriptional Addiction in Cancer.
@nl
P2860
P1433
P1476
Transcriptional Addiction in Cancer
@en
P2093
James E Bradner
P2860
P304
P356
10.1016/J.CELL.2016.12.013
P407
P577
2017-02-01T00:00:00Z